2022
Frontiers in Pediatrics, (2022).10, 10.3389/fped.2022.966904.
Immunogenicity and immunobridging of single dose HPV vaccine in Tanzanian girls – the DoRIS trial.
2022
(2022).
2022
The Lancet. Global health, (2022).10 6 10.1016/S2214-109X(22)00093-6.
2022
European journal of pediatrics, (2022).181 12 10.1007/s00431-022-04606-5.
2022
JOURNAL OF GLOBAL HEALTH, (2022).12, 10.7189/jogh.12.04029.
2022
Wellcome open research, (2022).7, 10.12688/wellcomeopenres.17419.1.
2022
PLOS Global Public Health, (2022).2 9 10.1371/journal.pgph.0000868.
2022
Global health : science and practice, (2022).10 1 10.9745/GHSP-D-21-00161.
2022
JAMA network open, (2022).5 12 10.1001/jamanetworkopen.2022.44772.
Evidence for One Dose HPV Vaccine: CVT, India-IARC trial and the DoRIS trial.
2022
(2022).